Ascendis Pharma A ASND
NASDAQ ASND
$238.90 +4.57 (+1.95%)
At close: Oct 21, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Construction in Progress (2019 - 2021)

Updated

Ascendis Pharma A (ASND) reported Construction in Progress of $2,174 for the quarter ended Dec 31, 2021, down 20.7% from $2,742 a year earlier.

Analysis

Ascendis Pharma A (ASND) Construction in Progress (2019 - 2021) Analysis & Trends

  • By year, Construction in Progress came in at $2,742 in the year ended Dec 31, 2020 (-99.9%) and $2.99 million in the year ended Dec 31, 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Ascendis Pharma A 14.48 Bn 10.74 Bn 362.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 2,151.76
Dec 31, 2020 2,828.98
Dec 31, 2019 3.02 Mn
API Access

Ascendis Pharma A Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=ASND&period=max&api_key=YOUR_API_KEY